The visual system adapts to the loss of photoreception by increasing sensitivity but simultaneously becomes deleteriously hyperactive. The findings could lead to new therapies to protect vision or reverse vision loss.
Determining the structure of vitronectin, a protein implicated in age-related macular degeneration and some neurodegenerative disorders, and using pressure to alter the protein shape may help in the development of new treatments for AMD.
People with subretinal drusenoid deposits (SDD), a form of age-related macular degeneration, are more likely to have underlying heart damage as a result of heart failure or heart attacks, or other forms of cardiovascular disease associated with increased stroke risk.
New AI technology is able to detect changes to the retina and predict the risk of retinal vein occlusion. Researchers say the technology could also be used to detect heart attack and stroke risks.
A new study reports amyloid beta proteins are able to accumulate in the retina and damage it, which may result in age related macular degeneration in older people.
New discoveries about neuroplasticity following vision loss could improve patient susceptibility to sensory prosthetics.
Antabuse, a drug commonly prescribed to treat alcohol use disorder, may help to restore eyesight in people with genetic retinitis pigmentosa and other disorders associated with retinal degeneration.
Researchers say Black patients are at greater risk of advanced vision loss than white patients following a diagnosis of primary open angle glaucoma.